Search Results 51-60 of 356 for ⚠선불 폰 텔래 @USIMMA 선불유심내구제최대회선⚠

  1. Publications - Marin Veldic, M.D. - Mayo Clinic

    Ercis M, Ozerdem A, Veldic M, Singh B, Coombes BJ, Biernacka JM, Lazaridis KN, Frye MA. Measuring the exposome in bipolar disorder. Bipolar Disord 2024 Aug; ...

  2. A Study to Evaluate Lung Function in Subjects with Idiopathic Pulmonary Fibrosis (IPF) After Taking BI 1015550 for 12 Weeks - Mayo Clinic

    The purpose of this trial is to demonstrate proof of concept of clinical activity of BI 1015550 on the change of Forced Vital Capacity (FVC) between baseline ...

  3. Publications - Fadi E. Shamoun, M.D. - Mayo Clinic

    2022 May; 24(5):1062-1072. Epub 2022 Mar 21. View PubMed; Tseng AS, Shamoun FE, Marks LA, Agrwal N. What antithrombotic therapy should I use for my patient ...

  4. First-in-Human Study of KO-947 in Non-Hematological Malignancies - Mayo Clinic

    If an MTD cannot be identified, a recommended phase 2 dose (RP2D) will be determined. In addition, two tumor specific extension cohorts may be conducted to ...

  5. Ophthalmology Physicians - Medical Professionals - Mayo Clinic

    Find ophthalmology Physicians at your nearest Mayo Clinic location. Learn about the conditions they treat and procedures performed.

  6. ... 5-,800 278000037,130504,GRFT ACLL ALLD DERM 8X16,"7,088.00" 278000037,130505,GRFT ACLL ALLD DERM 16X20,"17,720.00" 278000037,140092,GRFT TNDN ACHIL W/CALCNL ...

  7. Evaluation of the changes in glycemic and physiologic parameters (sleep, cardioadapatbility parameters) in non-diabetic patients being treated for obesity with GLP1 Agonist and GLP-1/ GIP agonist medications. - Mayo Clinic

    Glycemic control will be monitored using the Ultrahuman M1(UH-M1) continuous glucose monitoring system, while sleep and activity will be measured by the ...

  8. Publications - Mithun V. Shah, M.D., Ph.D. - Mayo Clinic

    2025 Jun 5; 155:107734 Epub 2025 June 05. View PubMed; Mohty R, Halwani A, Badar T, Alkhateeb H, Shah MV, Qin H, Kharfan-Dabaja MA. Malignancies after ...

  9. A Study to Compare Durvalumab vs Placebo Following Stereotactic Body Radiation Therapy in Early Stage Non-small Cell Lung Cancer Patients - Mayo Clinic

    The purpose of this study is to evaluate the effectiveness and safety of durvalumab versus placebo following Stereotactic Body Radiation Therapy (SBRT) in ...

  10. A Multi-Center Trial of the ProLung Test™ - Mayo Clinic

    The primary Study hypothesis is that the ProLung Test will demonstrate safety and efficacy in the risk stratification of patients with pulmonary lesions ...